548 related articles for article (PubMed ID: 8581064)
1. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
2. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
Kang YJ
Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000
[TBL] [Abstract][Full Text] [Related]
3. Glutathione stimulates A549 cell proliferation in glutamine-deficient culture: the effect of glutamate supplementation.
Kang YJ; Feng Y; Hatcher EL
J Cell Physiol; 1994 Dec; 161(3):589-96. PubMed ID: 7962140
[TBL] [Abstract][Full Text] [Related]
4. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
Kang YJ
Toxicology; 1994 Mar; 88(1-3):177-89. PubMed ID: 8160199
[TBL] [Abstract][Full Text] [Related]
5. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
6. Increased glutathione levels in quiescent, serum-stimulated NRK-49F cells are associated not with a response to growth factors but with nutrient repletion.
Kang YJ; Enger MD
J Cell Physiol; 1991 Aug; 148(2):197-201. PubMed ID: 1679059
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
Kable EP; Favier D; Parsons PG
Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
9. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil cytotoxicity in human colon HT-29 cells with moderately increased or decreased cellular glutathione level.
Chen MF; Chen LT; Boyce HW
Anticancer Res; 1995; 15(1):163-7. PubMed ID: 7733628
[TBL] [Abstract][Full Text] [Related]
11. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
Xu BH; Gupta V; Singh SV
Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase.
Messina JP; Lawrence DA
J Immunol; 1989 Sep; 143(6):1974-81. PubMed ID: 2789253
[TBL] [Abstract][Full Text] [Related]
13. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function.
Smyth MJ
J Immunol; 1991 Mar; 146(6):1921-7. PubMed ID: 2005386
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of cytostatic effect of recombinant human lymphotoxin and involvement of glutathione redox cycle.
Matsunaga K; Mashiba H
Eur Cytokine Netw; 1992; 3(3):307-11. PubMed ID: 1498261
[TBL] [Abstract][Full Text] [Related]
15. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
16. Lack of a role of glutathione in cellular nonenzymatic activation of BMS-181174, a novel analogue of mitomycin C.
Xia H; Pinto T; Hu X; Benson PJ; Zaren HA; Gupta V; Singh S
Cancer Res; 1996 Aug; 56(15):3495-8. PubMed ID: 8758917
[TBL] [Abstract][Full Text] [Related]
17. The role of glutathione in the aerobic radioresponse. I. Sensitization and recovery in the absence of intracellular glutathione.
Clark EP; Epp ER; Morse-Gaudio M; Biaglow JE
Radiat Res; 1986 Dec; 108(3):238-50. PubMed ID: 3797633
[TBL] [Abstract][Full Text] [Related]
18. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
[TBL] [Abstract][Full Text] [Related]
19. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
Hamilos DL; Wedner HJ
J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
[TBL] [Abstract][Full Text] [Related]
20. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line.
Armstrong JS; Steinauer KK; Hornung B; Irish JM; Lecane P; Birrell GW; Peehl DM; Knox SJ
Cell Death Differ; 2002 Mar; 9(3):252-63. PubMed ID: 11859408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]